Cefopodoxime Proxotile IP 50mg (with SWFI) PODOCEF 50(SWFI)

Pemetrexed Injection is an anti-metabolite chemotherapy agent indicated for use in non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. Pemetrexed injection works by disrupting folate-dependent processes needed for cancer cell growth and replication, thereby slowing or stopping tumor progression.

Pemetrexed injection is given by intravenous infusion over ten minutes, usually once every 21 days. Pemetrexed injection should be given by a doctor in a hospital or infusion clinic.

Rizochem Pharmaceuticals produces its oncology medications in accordance with World Health Organization Good Manufacturing Principles (WHO-GMP) and the International Organization for Standardization (ISO) to ensure the best possible quality, purity, and therapeutic accountability for worldwide distribution.

With more than a decade of advances in the pharmaceutical export business, Rizochem Pharmaceuticals supplies oncology and chemotherapy medicines worldwide.

We export to over 15 countries, including the UAE, Indonesia, Italy, Germany, and Brazil.

Our commitment provides the world’s leading authentic sources, on-time global shipping, cold-chain logistics, and competitive prices at the wholesale level.